Send feedback

MYBPC1 p.Gln467Glu

c.1399C>G · rs146314887 · VCV882507

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 4 submitters
AlphaMissense
likely benign
0.1209 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.014%, nfe)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
3
arthrogryposis, distal, type 1B

Computational evidence

Protein change
AlphaMissense0.1209likely benign
REVEL0.145moderately benign-leaning
SaProtLLR -8.26tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 1.5GERP 2.8, phastCons 1
Regional constrainto/e 0.82unconstrained · MANE · 53 kb · p 6e-11 · regional, not allelic
Overall
CADD22.5PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM Q442E vs ClinVar Q467E) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.014% European (non-Finnish) · 165/1,179,982 alleles
Filtering AF 0.0122% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0116%
Overall 0.0108% 174/1,613,924 alleles · ultra-rare
Ancestry group Frequency 1 in
Amishnot grpmax-eligible 0.548% 182
European (non-Finnish)grpmax 0.014% 7,151
Remaining individualsnot grpmax-eligible 0.0048% 20,829
African / African-American 0.00134% 74,884

Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MYBPC1
Protein
p.Gln467Glu
Coding
c.1399C>G
MANE Select
NM_002465
dbSNP
rs146314887
Type
single nucleotide variant
Location
chr12:101651266 (GRCh38)
Gene constraint
LOEUF 0.433 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 81.99 · 8 PDB
Residue 467
the ig-like c2-type 4 domain
Full MYBPC1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mybpc1-p-gln467glu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown